Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Financial Flexibility Index
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of CN¥1.90 Billion (operating CF CN¥1.25 Billion minus capex CN¥652.49 Million) represents 0% of total liabilities (CN¥8.77 Billion). Check strategic asset allocation of Starlake Bioscience Co Inc Zhaoqing Guan to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. See Starlake Bioscience Co Inc Zhaoqing Guan (600866) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year free cash flow to debt coverage for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full company profile including market capitalisation, see 600866 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥3.33 Billion | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -18.6% |
| 2024 | 0.47x | CN¥3.04 Billion | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +30.4% |
| 2023 | 0.36x | CN¥2.40 Billion | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +53.2% |
| 2022 | 0.23x | CN¥2.11 Billion | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -59.1% |
| 2021 | 0.57x | CN¥397.71 Million | CN¥192.63 Million | CN¥697.74 Million | ▼ -20.5% |
| 2020 | 0.72x | CN¥539.88 Million | CN¥249.99 Million | CN¥752.97 Million | ▲ +15.3% |
| 2019 | 0.62x | CN¥370.58 Million | CN¥213.17 Million | CN¥595.95 Million | ▲ +260.2% |
| 2018 | 0.17x | CN¥84.40 Million | CN¥50.69 Million | CN¥488.94 Million | ▲ +14.4% |
| 2017 | 0.15x | CN¥80.66 Million | CN¥40.05 Million | CN¥534.57 Million | ▲ +18.2% |
| 2016 | 0.13x | CN¥81.43 Million | CN¥41.17 Million | CN¥637.90 Million | ▼ -4.4% |
| 2015 | 0.13x | CN¥106.23 Million | CN¥2.75 Million | CN¥795.88 Million | ▲ +279.4% |
| 2014 | 0.04x | CN¥27.70 Million | CN¥-20.22 Million | CN¥787.37 Million | ▼ -46.2% |
| 2013 | 0.07x | CN¥74.46 Million | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +568.5% |
| 2012 | 0.01x | CN¥16.62 Million | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -98.3% |
| 2011 | 0.57x | CN¥925.40 Million | CN¥65.88 Million | CN¥1.62 Billion | ▼ -20.4% |
| 2010 | 0.72x | CN¥501.03 Million | CN¥104.63 Million | CN¥698.07 Million | ▼ -9.7% |
| 2009 | 0.79x | CN¥379.33 Million | CN¥316.73 Million | CN¥477.36 Million | ▲ +131.9% |
| 2008 | 0.34x | CN¥198.90 Million | CN¥148.93 Million | CN¥580.44 Million | ▲ +32.4% |
| 2007 | 0.26x | CN¥157.18 Million | CN¥82.28 Million | CN¥607.29 Million | ▲ +18.9% |
| 2006 | 0.22x | CN¥112.52 Million | CN¥35.14 Million | CN¥516.89 Million | ▼ -8.6% |
| 2005 | 0.24x | CN¥116.60 Million | CN¥46.83 Million | CN¥489.57 Million | ▼ -60.8% |
| 2004 | 0.61x | CN¥249.81 Million | CN¥29.05 Million | CN¥410.86 Million | ▼ -37.6% |
| 2003 | 0.97x | CN¥259.83 Million | CN¥149.70 Million | CN¥266.82 Million | ▼ -32.2% |
| 2002 | 1.44x | CN¥271.37 Million | CN¥183.18 Million | CN¥188.89 Million | ▲ +155.7% |
| 2001 | 0.56x | CN¥138.17 Million | CN¥60.82 Million | CN¥245.97 Million | ▲ +16.0% |
| 2000 | 0.48x | CN¥160.58 Million | CN¥93.41 Million | CN¥331.53 Million | ▼ -47.4% |
| 1999 | 0.92x | CN¥132.42 Million | CN¥52.97 Million | CN¥143.87 Million | ▼ -17.6% |
| 1998 | 1.12x | CN¥184.87 Million | CN¥71.14 Million | CN¥165.54 Million | — |